Adherence to highly active antiretroviral therapy and its correlates among HIV infected pediatric patients in Ethiopia

被引:56
|
作者
Biadgilign, Sibhatu [2 ]
Deribew, Amare [2 ]
Amberbir, Alemayehu [3 ]
Deribe, Kebede [1 ]
机构
[1] Fayyaa Integrated Dev Assoc NCMI, PEPFAR New Partners Initiat, Addis Ababa, Ethiopia
[2] Jimma Univ, Publ Hlth Fac, Dept Epidemiol & Biostat, Jimma, Ethiopia
[3] Univ Addis Ababa, Sch Publ Hlth, Butajira Birth Cohort Project, Addis Ababa, Ethiopia
关键词
D O I
10.1186/1471-2431-8-53
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: The introduction of combination antiretroviral therapy (ART) has resulted in striking reductions in HIV-related mortality. Despite increased availability of ART, children remain a neglected population. This may be due to concerns that failure to adhere appears to be related to continued viral replication, treatment failure and the emergence of drug-resistant strains of HIV. This study determines the rates and factors associated with adherence to Antiretroviral (ARV) Drug therapy in HIV-infected children who were receiving Highly Active Antiretroviral Therapy (HAART) in Addis Ababa, Ethiopia in 2008. Methods: A cross-sectional study was conducted in five hospitals in Addis Ababa from February 18-April 28, 2008. The study population entailed parents/caretaker and index children who were following ART in the health facilities. A structured questionnaire was used for data collection. Results: A total of 390 children respondents were included in the study with a response rate of 91%. The majority, equaling 205 (52.6%) of the children, were greater than 9 years of age. Fifty five percent of the children were girls. A total of 339 children (86.9%) as reported by caregivers were adherent to antiretroviral drugs for the past 7 days before the interview. Numerous variables were found to be significantly associated with adherence: children whose parents did not pay a fee for treatment [OR = 0.39 (95% CI: 0.16, 0.92)], children who had ever received any nutritional support from the clinic [OR = 0.34 ( 95% CI: 0.14, 0.79)] were less likely to adhere. Whereas children who took co-trimoxazole medication/syrup besides ARVs [OR = 3.65 ( 95% CI: 1.24, 10.74)], children who did not know their sero-status [OR = 2.53 ( 95% CI: 1.24, 5.19)] and children who were not aware of their caregiver's health problem [OR = 2.45 ( 95% CI: 1.25, 4.81)] were more likely to adhere than their counterparts. Conclusion: Adherence to HAART in children in Addis Ababa was higher than other similar setups. However, there are still significant numbers of children who are non-adherent to HAART.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients
    Sendi, PP
    Bucher, HC
    Harr, T
    Craig, BA
    Schwietert, M
    Pfluger, D
    Gafni, A
    Battegay, M
    AIDS, 1999, 13 (09) : 1115 - 1122
  • [42] Cardiovascular disease in HIV-infected patients on highly active antiretroviral therapy
    Jericó, C
    Knobel, H
    Carmona, A
    Sorli, ML
    López-Colomés, JL
    Pedro-Botet, J
    MEDICINA CLINICA, 2004, 122 (08): : 298 - 300
  • [43] Highly active antiretroviral therapy and cardiovascular complications in HIV-infected patients
    Barbaro, G
    Klatt, EC
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (18) : 1475 - 1481
  • [44] Autoimmune Diabetes in HIV-Infected Patients on Highly Active Antiretroviral Therapy
    Takarabe, Daisuke
    Rokukawa, Yuka
    Takahashi, Yoshihiko
    Goto, Atsushi
    Takaichi, Maki
    Okamoto, Masahide
    Tsujimoto, Tetsuro
    Noto, Hiroshi
    Kishimoto, Miyako
    Kaburagi, Yasushi
    Yasuda, Kazuki
    Yamamoto-Honda, Ritsuko
    Tsukada, Kunihisa
    Honda, Miwako
    Teruya, Katsuji
    Kajio, Hiroshi
    Kikuchi, Yoshimi
    Oka, Shinichi
    Noda, Mitsuhiko
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (08): : 4056 - 4060
  • [45] Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy
    Foulon, G
    Wislez, M
    Naccache, JM
    Blanc, FX
    Rabbat, A
    Israël-Biet, D
    Valeyre, D
    Mayaud, C
    Cadranel, J
    CLINICAL INFECTIOUS DISEASES, 2004, 38 (03) : 418 - 425
  • [46] Hospitalized HIV-Infected Patients in the Era of Highly Active Antiretroviral Therapy
    Metsch, Lisa R.
    Bell, Christine
    Pereyra, Margaret
    Cardenas, Gabriel
    Sullivan, Tanisha
    Rodriguez, Allan
    Gooden, Lauren
    Khoury, Nayla
    Kuper, Tamy
    Brewer, Toye
    del Rio, Carlos
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2009, 99 (06) : 1045 - 1049
  • [47] Dyspepsia in HIV-infected patients under highly active antiretroviral therapy
    Werneck-Silva, Ana Luiza
    Prado, Ivete Bedin
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (11) : 1712 - 1716
  • [48] Anemia in HIV-infected patients receiving highly active antiretroviral therapy
    Moore, RD
    Forney, D
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (01) : 54 - 57
  • [49] Insomnia in HIV infected patients in the era of highly active antiretroviral therapy (HAART)
    LaRocco, A
    Scott, WR
    Aiken, M
    Rutledge, CM
    Green, GE
    Rivera-Tyler, T
    Ford, A
    Ware, CJ
    SLEEP, 2004, 27 : 339 - 339
  • [50] Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in Southwest Ethiopia
    Amberbir, Alemayehu
    Woldemichael, Kifle
    Getachew, Sofonias
    Girma, Belaineh
    Deribe, Kebede
    BMC PUBLIC HEALTH, 2008, 8 (1)